Bank Of New York Mellon Corp Viking Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $430,537 - $1.49 Million	158,286 New	158,286 $1.49 Million
Q3 2022 Nov 14, 2022	SELL	$2.55 - $3.89 $4,182 - $6,379	-1,640 Reduced 1.55%	104,144 $284,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $464,124 - $692,886	-219,964 Reduced 67.53%	105,784 $306,000
Q1 2022 May 11, 2022	BUY	$3.0 - $4.88 $203,505 - $331,034	67,835 Added 26.3%	325,748 $977,000
Q4 2021 Feb 11, 2022	SELL	$4.6 - $6.72 $38,819 - $56,710	-8,439 Reduced 3.17%	257,913 $1.19 Million
Q3 2021 Nov 12, 2021	BUY	$5.58 - $7.04 $90,345 - $113,984	16,191 Added 6.47%	266,352 $1.67 Million
Q2 2021 Aug 11, 2021	SELL	$5.19 - $6.73 $254,932 - $330,577	-49,120 Reduced 16.41%	250,161 $1.5 Million
Q1 2021 May 13, 2021	SELL	$5.74 - $9.67 $2,847 - $4,796	-496 Reduced 0.17%	299,281 $1.89 Million
Q4 2020 Feb 09, 2021	SELL	$5.3 - $6.71 $64,972 - $82,257	-12,259 Reduced 3.93%	299,777 $1.69 Million
Q3 2020 Nov 12, 2020	SELL	$5.73 - $8.11 $15,161 - $21,459	-2,646 Reduced 0.84%	312,036 $1.82 Million
Q2 2020 Aug 12, 2020	SELL	$4.35 - $8.08 $2,114 - $3,926	-486 Reduced 0.15%	314,682 $2.27 Million
Q1 2020 May 06, 2020	BUY	$3.45 - $7.95 $13,368 - $30,806	3,875 Added 1.24%	315,168 $1.47 Million
Q4 2019 Feb 14, 2020	BUY	$6.38 - $8.73 $159,263 - $217,926	24,963 Added 8.72%	311,293 $2.5 Million
Q3 2019 Nov 07, 2019	SELL	$6.55 - $8.6 $541,501 - $710,979	-82,672 Reduced 22.4%	286,330 $1.97 Million
Q2 2019 Aug 12, 2019	BUY	$7.67 - $10.63 $376,037 - $521,157	49,027 Added 15.32%	369,002 $3.06 Million
Q1 2019 May 14, 2019	SELL	$7.58 - $9.94 $508,345 - $666,616	-67,064 Reduced 17.33%	319,975 $3.18 Million
Q4 2018 Feb 11, 2019	BUY	$7.16 - $16.21 $11,133 - $25,206	1,555 Added 0.4%	387,039 $2.96 Million
Q3 2018 Nov 09, 2018	BUY	$9.7 - $19.65 $382,713 - $775,290	39,455 Added 11.4%	385,484 $0
Q2 2018 Aug 06, 2018	BUY	$3.88 - $12.74 $1.24 Million - $4.09 Million	320,731 Added 1267.81%	346,029 $3.28 Million
Q1 2018 May 15, 2018	BUY	$4.11 - $6.93 $103,974 - $175,315	25,298 New	25,298 $110,000

Others Institutions Holding VKTX

# of Institutions

473

Shares Held

66.2M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account